APTOCROM (A109960) Stock Overview
Distributes pharmaceutical products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
A109960 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
APTOCROM Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩269.00 |
| 52 Week High | ₩654.00 |
| 52 Week Low | ₩259.00 |
| Beta | 0.17 |
| 1 Month Change | -14.33% |
| 3 Month Change | -32.41% |
| 1 Year Change | -43.37% |
| 3 Year Change | -85.84% |
| 5 Year Change | -93.37% |
| Change since IPO | -95.11% |
Recent News & Updates
Shareholder Returns
| A109960 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -3.2% | -0.8% | -3.9% |
| 1Y | -43.4% | 56.9% | 51.2% |
Return vs Industry: A109960 underperformed the KR Biotechs industry which returned 51.5% over the past year.
Return vs Market: A109960 underperformed the KR Market which returned 58% over the past year.
Price Volatility
| A109960 volatility | |
|---|---|
| A109960 Average Weekly Movement | 5.3% |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 10.9% |
| 10% least volatile stocks in KR Market | 2.5% |
Stable Share Price: A109960 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A109960's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 12 | n/a | www.aprogen-hng.com |
APTOCROM Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025. APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
APTOCROM Inc. Fundamentals Summary
| A109960 fundamental statistics | |
|---|---|
| Market cap | ₩59.38b |
| Earnings (TTM) | -₩66.83b |
| Revenue (TTM) | ₩12.15b |
Is A109960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A109960 income statement (TTM) | |
|---|---|
| Revenue | ₩12.15b |
| Cost of Revenue | ₩9.79b |
| Gross Profit | ₩2.36b |
| Other Expenses | ₩69.19b |
| Earnings | -₩66.83b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -302.75 |
| Gross Margin | 19.41% |
| Net Profit Margin | -549.87% |
| Debt/Equity Ratio | 2.0% |
How did A109960 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/21 17:23 |
| End of Day Share Price | 2025/11/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
APTOCROM Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.